Literature DB >> 2009755

Obstructive sleep apnea presenting with nocturnal angina, heart failure, and near-miss sudden death.

H S Chan1, H F Chiu, L K Tse, K S Woo.   

Abstract

An obese woman with a one-year history of episodic nocturnal chest pain was admitted because of shock and pulmonary edema. A clinical diagnosis of acute myocardial infarction and cardiogenic shock was made. She was ventilated and successfully resuscitated. Subsequent investigations showed no evidence of cardiac dysfunction or coronary disease, but sleep study confirmed the diagnosis of obstructive sleep apnea syndrome (OSAS). We suggest that the nocturnal angina and heart failure in this patient might have resulted from extreme hypoxemia produced by OSAS. This case raised the possibility that the high cardiovascular mortality rate reported in OSAS might not necessarily relate to underlying coronary artery disease. Further investigations are required to delineate the true incidence of coronary disease in patients with OSAS.

Entities:  

Mesh:

Year:  1991        PMID: 2009755     DOI: 10.1378/chest.99.4.1023

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  4 in total

1.  Positive pressure on neck reduces baroreflex response to apnoea.

Authors:  V Lepicovska; P Novak; D Drozen; Z Fabian
Journal:  Clin Auton Res       Date:  1992-02       Impact factor: 4.435

Review 2.  Acute cardiopulmonary failure from sleep-disordered breathing.

Authors:  Gordon E Carr; Babak Mokhlesi; Brian K Gehlbach
Journal:  Chest       Date:  2012-03       Impact factor: 9.410

Review 3.  Obstructive sleep apnea syndrome (OSAS) and hypertension: pathogenic mechanisms and possible therapeutic approaches.

Authors:  Wang Zhang; Liang-yi Si
Journal:  Ups J Med Sci       Date:  2012-09-25       Impact factor: 2.384

4.  The Effects of Experimental Sleep Apnea on Cardiac and Respiratory Functions in 6 and 18 Month Old Dystrophic (mdx) Mice.

Authors:  Milind R Chaudhari; James A Fallavollita; Gaspar A Farkas
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.